Laparoscopic Methylene Blue Photodynamic Therapy for Intraabdominal Infection: A Preclinical Feasibility Study in a Rabbit Model of Perforated Appendicitis Authors: Timothy M. Baran, Korry T. Wirth, Matthew M. Byrne, Benjamin Gertsen, Eric Y. Wang, Darrian S. Hawryluk, Martin S. Pavelka, Nicole A. Wilson Published: 2026 ABSTRACT ABSTRACTObjectivesPerforated appendicitis commonly results in intra‐abdominal infection requiring prolonged antibiotic therapy. Intraoperative antimicrobial adjuncts are limited, and photodynamic therapy (PDT) may provide a targeted, resistance‐independent approach. This study evaluated the feasibility, safety, and preliminary antimicrobial effects of laparoscopic methylene blue photodynamic therapy (MB‐PDT) for intra‐abdominal disinfection in a rabbit model of perforated appendicitis.Materials and MethodsNew Zealand White rabbits (n = 19) underwent surgically induced perforated appendicitis via appendiceal ligation and electrocautery perforation. Animals subsequently received laparoscopic MB‐PDT (n = 9) or control treatment (methylene blue lavage without laser illumination; n = 10) 24–40 h after perforation. MB‐PDT consisted of peritoneal lavage with methylene blue (300 µg/mL) followed by 665‐nm laser illumination at 20 mW/cm2 to a fluence of 25 J/cm2. Peritoneal aspirates were obtained before and 24 h after intervention to quantify bacterial burden. In vitro PDT was evaluated in isolated organisms. Intraperitoneal organs were assessed histologically for off‐target effects. Primary outcomes were feasibility, safety, and in vivo change in bacterial burden. Secondary outcomes included clinical parameter changes and in vitro efficacy.ResultsFourteen rabbits developed peritonitis, and 10 animals completed follow‐up (PDT n = 7, control n = 3). Laparoscopic MB‐PDT delivery was technically feasible and no histologic evidence of off‐target photodynamic injury to abdominal organs was identified. Changes in bacterial burden were not significantly different between MB‐PDT and control animals (p = 0.18). Body temperature showed a non‐significant trend toward reduction following MB‐PDT (−0.37°C ± 1.32°C) compared with controls (0.26°C ± 0.76°C; p = 0.27). In vitro MB‐PDT produced significant reductions in bacterial burden across all isolated species (p < 0.001), with the most resistant Gram‐positive isolate, Enterococcus faecalis, demonstrating greater susceptibility than Gram‐negative species.ConclusionLaparoscopic MB‐PDT was technically feasible and safe in a rabbit model of perforated appendicitis. Although a reduction in bacterial burden was not observed in vivo, MB‐PDT produced strong antimicrobial activity in vitro against all bacterial species isolated from infected animals. These findings establish a preclinical technical platform for intra‐abdominal MB‐PDT and highlight the importance of optimized light‐delivery strategies for future translational studies. Introduction Appendicitis is one of the most common general surgical condition worldwide and remains a major source of morbidity and health care utilization [1, 2]. Approximately ⅓ of pediatric cases in the United States present with perforated appendicitis [3, 4], resulting in bacterial contamination of the peritoneal cavity and subsequent peritonitis. Contamination from perforated appendicitis is frequently polymicrobial, with Escherichia coli, Streptococcus species, Bacteroides fragilis, and Pseudomonas aeruginosa being the most common species isolated clinically [5, 6, 7]. Compared with nonperforated appendicitis, perforated appendicitis is associated with longer hospitalizations, higher costs, increased readmissions, and increased postoperative complications [3, 8, 9, 10, 11]. Antibiotics remain the cornerstone of treatment for intra‐abdominal infection associated with perforated appendicitis. However, the increasing prevalence of antimicrobial resistance underscores the urgent need for alternative adjunctive antimicrobial strategies. Photodynamic therapy (PDT) is a light‐activated antimicrobial approach in which a photosensitizer generates bactericidal reactive oxygen species upon illumination. Because the mechanism of action involves oxidative damage rather than traditional antimicrobial targets, PDT is broadly effective against diverse bacterial species, including antibiotic‐resistant organisms. However, while Gram‐negative bacteria may demonstrate reduced susceptibility due to the presence of an outer lipopolysaccharide membrane that can limit photosensitizer uptake and mitigate oxidative damage [12], clinically relevant acquired resistance to antimicrobial PDT has not been established [13, 14, 15]. Methylene blue (MB) is a well‐characterized photosensitizer that has demonstrated antimicrobial efficacy in a variety of clinical settings, including superficial infections [16, 17, 18, 19], nasal decontamination [20], and intra‐abdominal abscess treatment [21]. Although MB‐PDT has demonstrated strong in vitro activity against pathogens commonly isolated from intra‐abdominal infections [22, 23, 24, 25, 26, 27, 28, 29, 30], it has not been applied in vivo to treat the intra‐abdominal infection associated with perforated appendicitis. Whereas most PDT applications have focused on superficial infections or encapsulated abscesses [15, 21, 31], this study targets the open and complex environment of the peritoneal cavity, which presents unique technical challenges for light delivery and treatment uniformity. Delivering uniform light throughout the peritoneal cavity while avoiding injury to surrounding organs requires controlled light delivery and appropriate animal models for preclinical testing. Rabbits possess a well‐developed appendix [32] and therefore provide a useful platform for modeling perforated appendicitis [33, 34, 35, 36], though prior models have struggled to produce consistent appendiceal perforation and peritonitis [33, 34]. In this study, we sought to develop a rabbit model of perforated appendicitis with peritonitis and to evaluate the feasibility and safety of laparoscopic MB‐PDT for intra‐abdominal antimicrobial treatment. We further assessed the antimicrobial efficacy of MB‐PDT in vitro against bacterial species isolated from infected animals to confirm efficacy in the absence of complexities introduced by the in vivo model. We hypothesized that: (1) a rabbit model of perforated appendicitis with diffuse peritonitis could be established; (2) laparoscopic MB‐PDT could be safely delivered within the peritoneal cavity; and (3) MB‐PDT would demonstrate antimicrobial activity in vitro against bacteria associated with perforated appendicitis. We further explored whether intra‐abdominal MB‐PDT could reduce bacterial burden in vivo compared with control conditions. Methods All animal procedures were approved by the University Committee on Animal Resources at the University of Rochester Medical Center. Nineteen New Zealand White rabbits were purchased at 5–6 months of age (Charles River Laboratories, Wilmington, MA). This study was reported following the ARRIVE guidelines (Table S1). All rabbits received identical housing, enrichment, and diet. Pain was managed with a multimodal analgesic approach: pre‐operative intravenous buprenorphine (0.12 mg/kg), local anesthetic at the incision (1 mg/kg bupivacaine), and transdermal fentanyl patches (12–25 µg/hour). All animals underwent three surgical procedures over three distinct days (Figure 1): (1) induction of perforated appendicitis on Day 1, (2) PDT or control condition on Day 2 with pre‐intervention sample collection, and (3) postintervention sample collection and tissue harvesting on Day 3. Experimental design. Perforated appendicitis was induced on Day 1, followed by PDT or control treatment on Day 2 with pre‐intervention fluid collection. Postintervention fluid and tissue samples were collected on Day 3. (Created in BioRender. Wilson, N. (2025), https://BioRender.com/7vr9yjp). Induction of Perforated Appendicitis On Day 1, rabbits were anesthetized with ketamine (15–20 mg/kg) plus dexmedetomidine (0.05–0.1 mg/kg), maintained on isoflurane inhalation (1%–2%), and hemodynamically monitored throughout the surgery. A 1.5‐cm midline laparotomy was performed to expose the cecum and appendix (Figure 2a,b). The perforator vessels within the meso‐appendix were cauterized and divided. At the appendiceal base (~10 cm from the tip), the appendiceal artery was identified tactilely and suture ligated. Appendiceal artery ligation was intentionally not performed in the last treated animal. Once hemostasis was confirmed, the appendix was ligated at its base using a 1–0 absorbable monofilament (polydioxanone [PDS]) prelooped ligature (ENDOLOOP Ligature, Ethicon US, LLC, Raritan, NJ) (Figure 2b). A full‐thickness linear electrocautery burn was created on the anti‐mesenteric surface near the appendiceal base. Perforation was confirmed by extrusion of fecal material. The appendix and cecum were then placed back into the abdomen, taking care to avoid volvulus. The abdominal fascia was closed with braided absorbable suture (polyglactin 910), and the skin was closed with interrupted absorbable monofilament sutures (poliglecaprone 25). The incision was then covered with surgical glue (VetBond, 3 M), and a weight‐based dose of 1% bupivacaine was injected at the incision site as a local anesthetic. The rabbit was then returned to the vivarium for 24–40 h, during which time perforated appendicitis with diffuse peritonitis developed (Figure 2c). Representative images of the rabbit model of perforated appendicitis and MB‐PDT delivery. (a) Appendix prior to ligation (yellow arrow); (b) Ligated appendix; (c) Appendiceal perforation 24 h after ligation (yellow arrow); (d) Feculent peritonitis; (e) Necrotic appendix; (f) Methylene blue incubation; (g) Introduction of optical fiber into diluted Intralipid solution; (h) Laser light delivery. In Vivo PDT and Control Condition On Day 2, each rabbit was again anesthetized with isoflurane. The treatment window (from Day 1 to Day 2) ranged from 24 to 40 h during model development to allow sufficient time for infection establishment while maintaining animal survival. Under sterile conditions, a 5‐mm laparoscopic trocar was inserted into the superior aspect of the previous laparotomy incision, and the abdomen was insufflated with CO2 to a pressure of 4 mmHg. A 5‐mm, 30‐degree laparoscope was introduced into the abdomen to inspect and confirm the presence of perforation and feculent peritonitis (Figure 2d). Peritoneal aspirates were obtained using laparoscopic suction, evaluated as described below. Once peritoneal aspirates were obtained, the previous laparotomy incision was reopened. The cecum and appendix were exteriorized (Figure 2e). An appendectomy was performed using a second PDS prelooped ligature at the appendiceal base, approximately 1 cm from the first. The appendix was divided between the two ligatures using electrocautery. After inspecting the remaining enteric contents for injury and hemostasis, the colon and cecum were delivered back into the abdomen. The midline fascial incision was closed as described on Day 1. However, a 5‐mm defect was left to accommodate a single 5‐mm laparoscopic trocar. Following sample collection and appendectomy, rabbits were assigned to PDT (n = 9) or control conditions (n = 10). Rabbits were randomized (via random number generator) to receive either PDT (or control conditions) was then performed intraoperatively during the same procedure. For PDT animals, the entire peritoneal cavity was filled with 500 mL of warm, sterile, dilute MB (300 µg/mL) via peritoneal lavage using a standard reusable laparoscopic suction/irrigation device (Figure 2f). This MB concentration (300 µg/mL) was selected based on prior in vitro studies demonstrating high PDT efficacy against relevant organisms [23, 29, 30] and informed by spectroscopic measurements in human abscess cavities suggesting that higher concentrations may limit light penetration [37]. MB was incubated for 10 min to allow bacterial uptake while minimizing host tissue absorption [38]. The laparoscopic suction irrigator was then used to aspirate MB, and the peritoneal cavity was flushed twice with 500 mL of warm, sterile saline. Following MB incubation, the peritoneal cavity was then filled with 500 mL of 0.1% warm, sterile fat emulsion (Intralipid, Baxter Healthcare Corporation, Deerfield, IL) to enhance light scattering and promote more diffuse intraperitoneal illumination (Figure 2g). Immediately following this, a sterile, flat‐cleaved optical fiber with a 600 µm core diameter (Varilase Platinum Bright Tip, Vascular Solutions, Inc., Minneapolis, MN) was inserted under laparoscopic visualization to the approximate center of the abdominal cavity (Figure 2g). Care was taken to avoid direct contact of the laser fiber with the bowel. Laser light at 665 nm (ML7710, Modulight Corporation, Tampere, Finland) was then delivered at an irradiance of 20 mW/cm2 to a target radiant exposure (fluence) of 25 J/cm2 (Figure 2h), resulting in approximately 20 min of illumination. Peritoneal cavity dimensions and an assumption that the optical fiber was positioned centrally were used to determine the optical power necessary to achieve the desired irradiance at the peritoneal cavity wall. Illumination parameters were selected based on prior studies demonstrating effective antimicrobial activity with MB‐PDT in human intra‐abdominal abscesses [21], with the selected fluence (25 J/cm2) aligned with dosing parameters used in a planned Phase 2 clinical trial (ClinicalTrials.gov ID: NCT06052956). A detailed summary of radiometric and dosimetric parameters is provided in Table 1 to facilitate reproducibility. Table 1Radiometric and dosimetric parameters for In Vivo MB‐PDT.ParameterValueUnitsNotesWavelength665nmDiode laser (ML7710, Modulight)Irradiance20mW/cm2 Estimated at peritoneal cavity wallRadiant exposure (fluence)25J/cm2 Target delivered dose at peritoneal cavity wallRadiant power1571–2454mWCalculated based on individual cavity geometryRadiant energy1964–3068JPower × exposure time, calculated based on individual cavity geometryExposure time20.8minutesBased on irradiance and fluenceLight delivery systemFlat‐cleaved optical fiber—Varilase Platinum Bright TipOptical fiber core diameter600µmScattering medium0.1% Intralipid—Enhances diffuse illuminationJohn Wiley & Sons, Ltd. Radiometric and dosimetric parameters for In Vivo MB‐PDT. For the first five rabbits receiving PDT, the laser fiber was manually held and stabilized, with care taken to maintain the fiber stationary in the center of the cavity during light delivery. In the remaining PDT‐treated rabbits, a prototype laparoscopic device was used to introduce and stabilize the optical fiber during treatment (Figure 3) [39]. After illumination, the optical fiber was removed from the abdomen, and the Intralipid was aspirated using the laparoscopic suction‐irrigator. The peritoneal cavity was again flushed twice with warm, sterile saline until the effluent returned clear. The remaining saline was aspirated. Control animals received all procedures described above, but did not receive laser illumination. These controls, therefore, represent a drug‐only (MB) condition. This design isolates the photodynamic effect by controlling for potential antimicrobial activity of MB alone. Prototype laparoscopic device for PDT delivery. Top: Rendering of the device showing major components: articulating tip (A), rigid laparoscopic shaft (B), and handle (C). Central tubing (G) accommodates the optical fiber. Tip articulation is controlled using a wheel knob (D) and ratcheting trigger components (E–F). Bottom: Intraoperative deployment of the prototype laparoscopic device during a representative rabbit PDT procedure. After delivery of either PDT or control conditions, the laparoscopic trocars were withdrawn from the rabbit's abdomen and the fascia at all port sites was closed using absorbable braided suture. The skin was closed using absorbable monofilament suture and covered with surgical glue, as described above. The procedure was designed to replicate a laparoscopic workflow that could be adapted for future clinical intraoperative MB‐PDT delivery. Anesthesia was stopped and the rabbit was extubated at the end of the case. The rabbit was then returned to the vivarium for 24 h. Collection of Postintervention Samples and Tissue Harvesting Animals were sacrificed on Day 3, 24 h after PDT or control conditions. Immediately following sacrifice, a postintervention peritoneal aspirate was collected using the same procedure as the pre‐intervention sample collection on Day 2 (sterile collection under laparoscopic guidance). For animals with scant intra‐abdominal fluid present, the peritoneal cavity was rinsed with sterile saline. This saline was then aspirated to serve as the postintervention sample. After sterile collection of postintervention aspirates, the laparoscopic trocar was removed from the abdomen, and a midline laparotomy was performed. Small (~0.5 cm3) tissue samples were collected from the following organs to evaluate off‐target effects of intra‐abdominal PDT: (1) small intestine, (2) large intestine, (3) bladder, (4) liver, (5) stomach, (6) kidney, and (7) spleen. Tissue samples were placed in 10% formalin for at least 24 h before the histopathological evaluation described below. Evaluation of Clinical Parameters Rabbit vital signs, including body temperature, heart rate, and respiratory rate, were collected for all animals at five timepoints: (1) preligation on Day 1, (2) intraligation on Day 1, (3) postligation from Days 1–2, (4) intraintervention (PDT or control conditions) on Day 2, and (5) postintervention from Days 2–3. Body weight was also recorded on Days 1 and 2. Histopathology for Off‐Target Effects Tissue samples were fixed in 10% neutral buffered formalin for 72 h at 4°C, processed, and embedded in paraffin for sectioning. Five‐micron sections were cut and deparaffinized for Hematoxylin and Eosin (H&E) staining. Slides were scanned with the VS110 Virtual Slide Microscope (Olympus, Waltham, MA, USA) to visualize and assess for off‐target effects. A board‐certified pathologist, blinded to experimental conditions, selected two representative sections from each organ for each animal. A total of 64 slides were evaluated. Slides were evaluated for inflammation, necrosis, ischemic injury, vascular changes, edema, microorganisms, foreign material, and other structural abnormalities. Bacteriology Intra‐abdominal fluid aspirates were plated on BHI (Criterion Brain Heart Infusion (BHI)) Broth with 1.5% BD Bacto Agar, Difco MacConkey agar, and blood agar (Difco Columbia Broth with 1.5% BD Bacto Agar and 5% HemoStat Laboratories Defib Sheep Blood). Gram stain, oxidase, and indole tests were performed to initially classify the bacteria. Cultures were incubated aerobically (blood agar plates were incubated in candle jars to support growth of facultative organisms) at 37°C for 24 h. Bacterial burden was quantified as colony‐forming units per milliliter (CFU/mL) and log10‐transformed prior to analysis. Change in bacterial burden was defined as the difference between postintervention and pre‐intervention values (Δlog10 CFU/mL = log10[post] − log10[pre]). For samples with zero detectable colonies, a value of 1 CFU/mL was assigned prior to log transformation to allow inclusion in analysis. Genomic DNA samples were extracted from bacterial isolates by suspending a single colony in TRIS buffer (0.05 M, pH = 7.5) in a microcentrifuge tube and adding acid‐washed glass beads (425–600 μM, Sigma‐Aldrich). The tube was inserted into a bead homogenizer (Next Advance Bullet Blender Homogenizer, U.S Patent #5,769,538, Next Advance, NY) for 3 min to lyse the bacteria. The mixture was extracted, placed into a clean tube without beads, and stored at –20°C for later use. Polymerase chain reaction (PCR) amplifications of 16S rRNA gene sequences were performed using universal primers: (5’ AGA GTT TGA TCC TGG CTC AG3’) and (3’ ACG GCT ACC TTG TTA CGA CTT) and the iProof PCR kit (Bio‐Rad, CA). The following thermocycler settings were used: denaturation at 98°C for 3 min, 35 cycles [98°C for 60 s; 63°C for 45 s; 72°C for 45 s], and final elongation at 72°C for 5 min. PCR products were purified with the Monarch PCR & DNA Cleanup Kit (New England Biolabs, MA) and sequenced by Plasmidsaurus (Plasmidsaurus, CA) using Oxford Nanopore Technology with custom analysis and annotation. 16S rRNA gene sequences were identified using BLAST1 with 100% sequence coverage, an E‐value of 0.0, with 99%–100% identity. In Vitro PDT Isolated bacterial species were subjected to in vitro PDT to confirm antimicrobial susceptibility and to facilitate interpretation of in vivo findings. For in vitro experiments, bacteria were grown overnight on an orbital shaker at 37°C in 25 mL of BHI. Bacteria were harvested the next day by centrifugation at 5000 x g for 15 min at 4°C and washed twice with 25 mL of PBS. Samples were resuspended at an optical density of 1 at 600 nm. Eight 1 mL aliquots were prepared from the diluted samples. Four aliquots were incubated with MB (MB+) (Akorn, Inc., Lake Forest, IL) at a concentration of 300 µg/mL for 30 min at room temperature in a dark room on a rotating mount, and the remaining four with an equivalent volume of PBS (MB–). Following incubation, the samples were centrifuged at 10,000 x g for 10 min, washed twice with PBS using the same centrifugation settings, and then transferred to 12‐well tissue culture dishes for PDT experiments. Illumination was delivered by a lens‐tipped optical fiber coupled to a 665 nm laser (LDX‐3230‐665, LDX Optronics, Inc., Maryville, TN) at an irradiance of 4 mW/cm2 and fluence of 7.2 J/cm2, to replicate previously published conditions [23, 29, 30]. Each experiment also included control conditions: drug‐only (MB + L–), light‐only (MB–L+), and drug‐ and light‐free (MB–L–). Drug‐free controls (MB–) were prepared by replacing MB with PBS, as described above. Light‐free controls (L–) were placed in the same room as illuminated samples (L+) but shielded from laser light. After PDT or control conditions, suspensions were serially diluted in 96‐well tissue culture plates and incubated for approximately 18 h at 37°C. Statistical Analysis For in vivo experiments, changes in bacterial burden from pre to postintervention were compared between PDT and control conditions using the Mann–Whitney test. Given the small and imbalanced final sample size, in vivo analyses were considered exploratory, and nonparametric methods were selected to avoid assumptions of normality. Longitudinal changes in clinical parameters (weight, temperature, heart rate, respiratory rate) were analyzed using mixed‐effects models to account for repeated measures within animals. Comparisons between PDT and control conditions at individual timepoints and changes from pre‐ to postintervention were performed with the Mann–Whitney test. For in vitro experiments, bacterial burden was evaluated using a factorial design with two independent variables (MB and light exposure). Two‐way ANOVA was used to assess the main effects of each factor and their interaction. Reduction in bacterial burden for PDT versus drug‐ and light‐free controls was evaluated for each bacterial species using the Mann–Whitney test. All statistical analyses were performed using GraphPad Prism (v10.2.1, GraphPad Software, LLC, Boston, MA) and MATLAB (R2022b, The Mathworks, Inc., Natick, MA). No a priori power calculation was performed, as this study was designed as a pilot feasibility investigation. Accordingly, in vivo analyses were considered exploratory. Post hoc power calculations are included in the Results section, assuming α = 0.05 and a two‐tailed comparison between two independent means (G*Power 3.1.9.6, Franz Faul, Universität Kiel, Germany). Results Nineteen rabbits underwent attempted induction of perforated appendicitis. Fourteen developed peritonitis and 10 animals completed the full experimental protocol (PDT n = 7, control n = 3; Figure 4). All subsequent in vivo analyses are based on these animals. Given the final sample size and group imbalance, all in vivo comparisons between treatment groups are exploratory and descriptive, and are not intended to support conclusions regarding treatment efficacy. Study flow diagram illustrating animal enrollment, development of peritonitis, attrition across timepoints (with reasons for exclusion), allocation to PDT and control groups, and final numbers included in analysis. Post hoc power analysis indicated that the study was underpowered to detect moderate differences in bacterial burden between groups. Based on the observed effect size for change in bacterial burden (d = 1.60), the estimated power to detect this difference between groups was 52.9%. Rabbit Model of Perforated Appendicitis Fourteen of 19 rabbits developed perforated appendicitis with feculent peritonitis by Day 2. Frank purulence was observed in three animals and fibrinous adhesions in four. Three rabbits demonstrated no visible peritonitis at re‐exploration, and 4 died prior to the Day 2 procedure. Peritoneal aspirates obtained prior to intervention were available for 17 rabbits, including samples collected from two animals that subsequently died before surgical intervention. Appendiceal necrosis was apparent in all animals except the final MB‐PDT‐treated rabbit, in which the appendiceal artery was intentionally not ligated (Figure 2e); however, diffuse peritonitis remained present in that case. Bacteria isolated from rabbits on Day 2, prior to PDT or control conditions, are tabulated in Table 1. The most frequently isolated organisms were E. coli (58.8%, 10/17), Enterobacter hormaechei (29.4%, 5/17), and Enterococcus faecalis (23.5%, 4/17). Polymicrobial infections were present in 64.7% (11/17) of samples, while 35.3% (6/17) were monomicrobial. No microbial growth was observed in 2 (11.8%) aspirates Table 2. Table 2Microbial species identified in peritoneal aspirates collected prior to intervention on Day 2 (n = 17). Values represent the number (%) of samples containing each species.Bacterial species, no. (%) Escherichia coli 10 (58.8) Enterobacter hormaechei 5 (29.4) Enterococcus faecalis 4 (23.5) Klebsiella pneumoniae 3 (17.6) Raoultella planticola 2 (11.8) Bacillus species1 (5.9) Paenibacillus motobuensis 1 (5.9) Proteus mirabilis 1 (5.9) Candida species1 (5.9)John Wiley & Sons, Ltd. Microbial species identified in peritoneal aspirates collected prior to intervention on Day 2 (n = 17). Values represent the number (%) of samples containing each species. Eight of 19 rabbits died prior to the planned experimental endpoint. Four deaths occurred between Days 1 and 2, including one due to mesenteric volvulus with hemorrhagic ascites and diffuse bowel ischemia unrelated to appendicitis. Three animals died during the Day 2 intervention procedure (1 likely due to intra‐abdominal sepsis, one multifactorial including possible sepsis and anesthetic complications, and one due to an idiopathic cardiac condition confirmed on necropsy). One rabbit died between Days 2 and 3, likely due to overwhelming intra‐abdominal sepsis. A detailed summary of mortality, including timing, cause, and group allocation, is provided in Table S2. Among surviving animals, 7 received MB‐PDT and 3 received control treatment, all with complete follow‐up. Subsequent results, therefore, focus on these 10 animals (Figure 4). Bacterial Response to in Vivo PDT The primary in vivo outcome was change in bacterial burden from pre‐ to postintervention (Δlog10 CFU/mL = log10[post] − log10[pre]), which did not differ significantly between MB‐PDT‐treated animals and controls (median difference 2.7 log10 CFU/mL, 95% CI [–1.94, 4.98], p = 0.18, Mann–Whitney; Figure 5a). Bacterial burden decreased in one MB‐PDT‐treated animal, while increases were observed in the remaining animals across both groups (Figure 5b). Preliminary in vivo PDT efficacy. (a) Change in overall bacterial burden from pre to postintervention, for rabbits receiving PDT (n = 7) and control conditions (n = 3). Symbols represent individual animals, with solid horizontal lines representing median values across animals. Horizontal dotted lines indicate no change. (b) Bacterial burden, expressed as log10 CFU/mL. Change in bacterial burden represents Δlog10 CFU/mL (post—pre). Solid bars represent mean bacterial burden, with error bars representing standard deviation. Animals with iatrogenic thermal bowel injury are marked with an asterisk (*). Note that no quantifiable bacterial burden was obtained for animal Control—1. Samples with zero detectable colonies were assigned a value of 1 CFU/mL prior to log transformation. Clinical Response to In Vivo MB‐PDT Vital signs (temperature, heart rate, and respiratory rate) were monitored throughout the experiment (Figure 6). Body temperature consistently increased following appendiceal ligation (Figure 6a, postligation period), consistent with developing intra‐abdominal infection. During intervention (Figure 6a, intervention period), temperature decreased transiently before returning toward baseline. Body temperature trends increased following intervention in both groups, with substantial interanimal variability (Figure 6a, postintervention period). Rabbit clinical parameters. Longitudinal measurements of (a) temperature, (b) heart rate, and (c) respiratory rate for representative PDT‐treated (blue) and control animals (red). Times for the intraligation periods are presented relative to the start of the ligation procedure. Times for postligation and intra‐intervention periods are presented relative to the start of the intervention (PDT or control), and postintervention times are presented relative to the end of the intervention procedure. The intraligation period is shaded in blue, the postligation period is shaded in green, the intervention period is shaded in red, and the postintervention period is shaded in orange. Longitudinal changes in temperature, heart rate, and respiratory rate were not statistically significant for the MB‐PDT or control groups (Mixed‐effects models, Figure 7). There were no significant differences between MB‐PDT and control at any time point examined (Mann–Whitney). Substantial variability was observed across animals, with body temperature showing the strongest trend from pre to postintervention, although this was not statistically significant (PDT: −0.37 ± 1.32°C, Control: 0.26 ± 0.76°C; p = 0.27, Mann‐Whitney; Figure 8). Summary of rabbit clinical parameter results. (a) Temperature, (b) heart rate, and (c) respiratory rate across experimental time intervals. Each data point represents an individual animal. Horizontal lines indicate median values within each group (blue: PDT, red: control). Change in rabbit clinical parameters. Change in (a) temperature, (b) heart rate, and (c) respiratory rate from the postligation to postintervention period. Individual data points represent mean values for each animal, with horizontal lines representing medians across all animals within a particular group (blue: PDT, red: control). Horizontal dotted lines indicate no change from baseline. Evaluation of Off‐Target Effects of In Vivo Pdt No histologic evidence of off‐target photodynamic injury was observed in evaluated intra‐abdominal organs (stomach, liver, kidney, small bowel, colon, bladder, spleen). Histologic examination of intra‐abdominal organs demonstrated findings consistent with feculent peritonitis in nine animals (seven PDT group, two Control group). Small intestinal perforation was identified histologically in one animal (PDT group) and confirmed on necropsy in two animals on Day 3 (both in PDT group). These findings were distinct from the two iatrogenic thermal bowel injuries described below. Both observed thermal injuries occurred during manual fiber stabilization, and none were observed after introduction of the prototype stabilization device. Because these perforations may have influenced bacterial burden measurements, the analysis shown in Figure 5 was repeated, excluding these animals. Results remained non‐significant (2.80 ± 2.74 log10 CFU/mL vs. 3.14 ± 2.33 log10 CFU/mL; p = 0.39, Mann–Whitney). In Vitro Efficacy of PDT Against Bacteria Isolated From a Rabbit Model of Perforated Appendicitis Reductions in bacterial burden relative to drug‐ and light‐free controls for individual bacterial species are shown in Figure 9. PDT significantly reduced bacterial burden for all species tested (p < 0.001 in all cases, 2‐way ANOVA), confirming preserved antimicrobial activity in vitro, with reductions exceeding 3 log10 CFU in several isolates. The Gram‐positive isolate, E. faecalis, demonstrated greater susceptibility to MB‐PDT than the Gram‐negative species tested. In vitro PDT efficacy. Reduction in bacterial burden for PDT‐treated samples (MB + L + ) relative to drug‐ and light‐free controls (MB–L–) for individual bacterial species isolated from infected animals. Solid bars indicate mean values across samples, with error bars representing standard deviation. Bacterial species isolated from a single sample do not include error bars. Discussion This preclinical feasibility study demonstrates that laparoscopic MB‐PDT can be delivered within the peritoneal cavity in a rabbit model of perforated appendicitis. Prior studies have demonstrated antimicrobial PDT efficacy in superficial infections [18, 19], endodontic infections [16, 17], nasal decontamination [20], and image‐guided treatment of encapsulated intra‐abdominal abscesses [21]. In contrast, the present study evaluates PDT in the open, anatomically complex environment of the peritoneal cavity, where illumination is less controlled, and contamination is diffuse rather than contained. Although a reduction in bacterial burden was not observed in this small and unbalanced in vivo cohort, MB‐PDT demonstrated strong antimicrobial activity in vitro against bacterial species isolated from this model, consistent with prior reports of broad antimicrobial PDT activity [15]. Taken together, these findings suggest that the absence of measurable in vivo efficacy in this study more likely reflects technical limitations of intraperitoneal light delivery, infection heterogeneity, and model variability, rather than a failure of the antimicrobial PDT mechanism itself. Preclinical models that closely replicate perforated appendicitis are essential for evaluating intra‐abdominal antimicrobial interventions. Multiple groups have reported rabbit models of appendicitis using appendiceal ligation [33, 34, 35, 36], but we observed wider variability in infection severity despite consistent surgical technique, animal sources, and housing conditions. Infection severity led to early mortality in 6 of 19 rabbits; 2 animals died for reasons seemingly unrelated to infection (mesenteric volvulus, idiopathic cardiac condition). Importantly, early mortality prior to intervention may have introduced survival bias, as animals with the most severe infection may not have survived to treatment or analysis. This could result in underestimation of treatment effect or altered baseline comparability between groups. Because mortality events occurred across multiple phases of the experiment and were not uniformly attributable to treatment, survival was not considered a reliable endpoint for comparative analysis in this study. In addition, differential attrition between groups contributed to imbalance in final sample sizes, further limiting interpretability of comparative analyses. These factors highlight challenges in model stability and underscore the need for more reproducible preclinical systems for evaluation of intra‐abdominal antimicrobial therapies. Additional challenges of model development included the fact that, unlike prior reports, a partial thickness cautery burn of the distal appendix tip did not result in a reproducible perforation after 24 h. In two animals, partial‐thickness burns healed without perforation, prompting a transition to full‐thickness cautery perforations. We also found that omitting appendiceal artery ligation resulted in peritonitis without appendiceal necrosis, potentially offering a more clinically relevant model, while avoiding the presence of a dead organ in the peritoneal cavity and the associated intra‐abdominal sepsis burden. Attempts to induce infection using defined microbial inoculation were performed in a limited number of pilot animals, but did not reliably produce peritonitis. Accordingly, a native polymicrobial infection model was used, which more closely reflects the clinical microbiology and heterogeneity of perforated appendicitis. The variability in infection severity, bacterial burden, and interval between infection induction and treatment may have further limited the ability to detect a treatment effect. Notably, the animal with the highest pretreatment bacterial burden was the only case demonstrating a post‐PDT reduction. The discrepancy between strong in vitro antimicrobial activity and the absence of measurable in vivo bacterial reduction likely reflects both model variability and limitations of light delivery within the peritoneal cavity. Unlike drained abscess cavities, in which we have previously deployed MB‐PDT clinically [21], the peritoneal cavity is an open, anatomically complex space with mobile organs, variable fluid distribution, and nonuniform surface geometry. As a result, the assumption of uniform irradiance throughout the cavity is unlikely to hold. Delivered irradiance varies nonlinearly with distance from the light source [40, 41], and regions of contamination may be partially shielded by bowel or solid organs. Although intraperitoneal lipid emulsion was used to enhance scattering and promote more diffuse illumination, scattering alone cannot eliminate shadowing or ensure uniform mixing throughout the cavity. Consequently, some infected surfaces may have received subtherapeutic light exposure despite delivery of the intended nominal radiant exposure. Prior treatment planning and simulation studies in abdominopelvic abscesses have similarly emphasized the importance of cavity geometry, optical properties, and diffuser configuration for achieving adequate light distribution [40, 41, 42]. These considerations are likely even more important for peritoneal PDT and may explain why preserved antimicrobial activity under controlled in vitro conditions did not translate into measurable bacterial reduction in vivo. Future studies will require improved light delivery strategies, including optimized diffuser geometry, device stabilization, and potentially real‐time or patient‐specific dosimetry. In addition to light‐delivery limitations, biologic differences between in vitro and in vivo conditions may have contributed to the discrepant findings. In vitro experiments provide controlled photosensitizer exposure, uniform illumination, oxygen availability, and predominantly planktonic bacterial conditions. In contrast, intra‐abdominal infection includes tissue‐associated bacteria, fibrinous debris, purulence, and polymicrobial communities that may limit effective photosensitizer uptake. Bacteria adherent to tissue surfaces or embedded within early biofilm‐like aggregates may be less accessible to MB than planktonic organisms in suspension [23, 43]. Local oxygen availability may also vary within inflamed or poorly perfused tissues, potentially limiting reactive oxygen species generation during PDT [44, 45]. These biologic factors, together with heterogeneous light delivery, may explain why antimicrobial activity observed under controlled in vitro conditions did not translate into measurable in vivo bacterial reduction. An additional technical challenge encountered during early experiments was maintaining stable positioning of the optical fiber within the peritoneal cavity. Although the target irradiance used in this study was low (20 mW/cm2), direct contact between the optical fiber and bowel can result in locally elevated irradiance and thermal injury. In two animals, presumed iatrogenic thermal injury to the small intestine was observed, both occurring during early experiments in which the optical fiber was manually held during illumination. To address this limitation, we developed a prototype laparoscopic device designed to stabilize the optical fiber and maintain a consistent position within the abdominal cavity. Use of this device improved reproducibility of fiber placement and reduced operator fatigue during illumination. Further refinement of similar stabilization systems may be important for achieving reliable and safe intra‐abdominal MB‐PDT delivery in future preclinical and clinical applications. Limitations Several limitations should be considered when interpreting these findings. The rabbit model demonstrated variability in infection and high mortality, which limited the final sample size and reduced statistical power for detecting in vivo antimicrobial effects. As a result, comparisons between PDT and control groups should not be interpreted as evidence of treatment effect, but rather as descriptive observations within a feasibility study. Microbiologic characterization was limited by predominantly aerobic conditions and may not have captured anaerobic organisms that contribute to perforated appendicitis. Important limitations also relate to PDT delivery and dosing. Only a single combination of drug and light parameters was examined in vivo, and delivered light doses likely varied due to uncertainty in optical fiber positioning and assumptions regarding uniform light distribution within the peritoneal cavity. Although high antimicrobial efficacy was observed in vitro at lower light doses, the drug‐light combination used in vivo may not have been optimal. However, similar parameters demonstrated efficacy in a recent Phase I clinical trial of intra‐abdominal abscesses in humans [21]. The selection of MB concentration also reflects a tradeoff between antimicrobial efficacy and optical penetration, which may be particularly important in the heterogeneous environment of the peritoneal cavity. These findings highlight key considerations for future study design, including the need for improved control of infection burden at the time of intervention and more consistent intraperitoneal light delivery. Alternative models of intra‐abdominal infection, such as rodent cecal ligation and puncture or bacterial inoculation models, may provide more reproducible infection and allow higher‐throughput evaluation of PDT dosing and delivery strategies [46, 47]. This study establishes the technical feasibility of laparoscopic MB‐PDT for intra‐abdominal antimicrobial treatment and demonstrates robust in vitro activity against clinically relevant pathogens associated with perforated appendicitis. Because MB is already widely used clinically and laparoscopic access to the peritoneal cavity is routine in the management of intra‐abdominal infection, the MB‐PDT approach described here could potentially be incorporated into existing surgical workflows if effective light delivery strategies can be established. Continued development of optimized light delivery strategies, dosing parameters, and infection models will be essential to determine whether intraoperative MB‐PDT can serve as a clinically useful adjunct for the treatment of intra‐abdominal infection. Together, these findings extend prior work by demonstrating the feasibility of intra‐abdominal MB‐PDT delivery in a clinically relevant model, while highlighting key challenges that must be addressed to achieve therapeutic efficacy. Ethics Statement All animal procedures were approved by the University Committee on Animal Resources at the University of Rochester Medical Center. Conflicts of Interest Timothy M. Baran, Nicole A. Wilson, and Korry T. Wirth are co‐inventors on a pending U.S. patent application related to a device for photodynamic therapy delivery (U.S. Patent Application No. 19/226,941). The authors report no other conflicts of interest. Supporting information Supporting File 1 Supporting File 2